| Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease J Kozlitina, E Smagris, S Stender, BG Nordestgaard, HH Zhou, ... Nature genetics 46 (4), 352-356, 2014 | 1274 | 2014 |
| HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials DI Swerdlow, D Preiss, KB Kuchenbaecker, MV Holmes, JEL Engmann, ... The Lancet 385 (9965), 351-361, 2015 | 755 | 2015 |
| A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease NS Abul-Husn, X Cheng, AH Li, Y Xin, C Schurmann, P Stevis, Y Liu, ... New England Journal of Medicine 378 (12), 1096-1106, 2018 | 724 | 2018 |
| Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci S Stender, J Kozlitina, BG Nordestgaard, A Tybjærg-Hansen, HH Hobbs, ... Nature genetics 49 (6), 842-847, 2017 | 357 | 2017 |
| Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver P Dongiovanni, S Stender, A Pietrelli, RM Mancina, A Cespiati, S Petta, ... Journal of internal medicine 283 (4), 356-370, 2018 | 327 | 2018 |
| Elevated body mass index as a causal risk factor for symptomatic gallstone disease: a Mendelian randomization study S Stender, BG Nordestgaard, A Tybjærg‐Hansen Hepatology 58 (6), 2133-2141, 2013 | 207 | 2013 |
| Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals BK Lauridsen, S Stender, TS Kristensen, KF Kofoed, L Køber, ... European heart journal 39 (5), 385-393, 2018 | 196 | 2018 |
| Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study M Benn, A Tybjærg-Hansen, S Stender, R Frikke-Schmidt, ... Journal of the National Cancer Institute 103 (6), 508-519, 2011 | 188 | 2011 |
| Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population H Gellert‐Kristensen, TG Richardson, G Davey Smith, BG Nordestgaard, ... Hepatology 72 (3), 845-856, 2020 | 185 | 2020 |
| Adeno-associated viral vector transduction of human mesenchymal stem cells S Stender, M Murphy, T O’Brien, C Stengaard, M Ulrich-Vinther, K Soballe, ... Eur Cell Mater 13 (93-99), 99, 2007 | 129 | 2007 |
| rs641738C> T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis K Teo, KWM Abeysekera, L Adams, E Aigner, QM Anstee, JM Banales, ... Journal of hepatology 74 (1), 20-30, 2021 | 113 | 2021 |
| Genetically elevated bilirubin and risk of ischaemic heart disease: three M endelian randomization studies and a meta‐analysis S Stender, R Frikke‐Schmidt, BG Nordestgaard, P Grande, ... Journal of internal medicine 273 (1), 59-68, 2013 | 106 | 2013 |
| Four susceptibility loci for gallstone disease identified in a meta-analysis of genome-wide association studies AD Joshi, C Andersson, S Buch, S Stender, R Noordam, LC Weng, ... Gastroenterology 151 (2), 351-363. e28, 2016 | 95 | 2016 |
| Genetic variation in the cholesterol transporter NPC1L1, ischaemic vascular disease, and gallstone disease BK Lauridsen, S Stender, R Frikke-Schmidt, BG Nordestgaard, ... European heart journal 36 (25), 1601-1608, 2015 | 84 | 2015 |
| High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase–Lowering Effect of a HSD17B13 Variant H Gellert‐Kristensen, BG Nordestgaard, A Tybjærg‐Hansen, S Stender Hepatology 71 (1), 56-66, 2020 | 79 | 2020 |
| The ABCG5/8 cholesterol transporter and myocardial infarction versus gallstone disease S Stender, R Frikke-Schmidt, BG Nordestgaard, A Tybjærg-Hansen Journal of the American College of Cardiology 63 (20), 2121-2128, 2014 | 67 | 2014 |
| Metabolic and genetic risk factors are the strongest predictors of severity of alcohol-related liver fibrosis M Israelsen, HB Juel, S Detlefsen, BS Madsen, DN Rasmussen, ... Clinical Gastroenterology and Hepatology 20 (8), 1784-1794. e9, 2022 | 66 | 2022 |
| Extreme bilirubin levels as a causal risk factor for symptomatic gallstone disease S Stender, R Frikke-Schmidt, BG Nordestgaard, A Tybjærg-Hansen JAMA internal medicine 173 (13), 1222-1228, 2013 | 65 | 2013 |
| Sterol transporter adenosine triphosphate–binding cassette transporter G8, gallstones, and biliary cancer in 62,000 individuals from the general population S Stender, R Frikke‐Schmidt, BG Nordestgaard, A Tybjærg‐Hansen Hepatology 53 (2), 640-648, 2011 | 60 | 2011 |
| Relationship between genetic variation at PPP1R3B and levels of liver glycogen and triglyceride S Stender, E Smagris, BK Lauridsen, KF Kofoed, BG Nordestgaard, ... Hepatology 67 (6), 2182-2195, 2018 | 59 | 2018 |
